Enlivex Therapeutics Ltd.
NASDAQ: ENLV
Healthcare
Biotechnology
Global Rank
#48956
Country Rank
#571
Market Cap
1.81 M
Price
1.46
Change (%)
18.26%
Volume
77,865
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) Stock Split History
This company has undergone a total of four stock splits throughout its history. Four reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 10/27/2026 with a ratio of 1-for-16. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 10/27/2026 | 1:16 | x0.0625 | x0.0001041667 | Reverse |
| 07/09/2026 | 1:15 | x0.06666667 | x0.001666667 | Reverse |
| 03/06/2019 | 1:8 | x0.125 | x0.025 | Reverse |
| 09/25/2017 | 1:5 | x0.2 | x0.2 | Reverse |
Frequently Asked Questions
-
How much would Enlivex Therapeutics Ltd. stock be worth if it never split?If Enlivex Therapeutics Ltd. (stock symbol: NASDAQ: ENLV) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-16) that occurred on 10/27/2026.
-
Has Enlivex Therapeutics Ltd. stock ever split?Enlivex Therapeutics Ltd. (stock symbol: NASDAQ: ENLV) has undergone a total of four stock splits. The most recent split occurred on 10/27/2026. One share bought prior to the first split on 09/25/2017 would now equal 0.00 shares.
-
Will Enlivex Therapeutics Ltd. stock split again?Enlivex Therapeutics Ltd. (stock symbol: NASDAQ: ENLV) has undergone four stock splits in its history. The most recent split, a 1-for-5 split, occurred on 10/27/2026. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.